Search Drugs Search BNF Categories Notes Click to View ALL BNF

>> >>
(Click to View Drug List)

Formulary Notes (BNF Chapter)

NICE Guidance (15)

Other Links (5)

Important Local Documents (5)

Notes for: Endocrine system
Last edited [18/11/2024 10:56:02]

Sharps Bins disposal

Cornwall Council: sharps bins collections information or 0300 1234 141

Isles of Scilly Council: For advice and disposal arrangements please contact St Mary's Hospital on 01720 422392

Last edited [18/11/2024 10:56:48]

Cornwall Joint Formulary Recommended Choices (...Top)

Displaying 23 Drugs

Key:

First Line Drugs

Second Line Drugs

Specialist advised

Specialist Initiated Drugs

Hospital Only Drugs

Discouraged

No comment available

	Name	Tariff	BNF Sub Paragraph
	Insulin isophane human 10 units/ml suspension for injection 10ml vials Pack of 1	£7.48	Intermediate And Long-Acting Insulins
	Humulin I Vial 10 ml Vial (100units / ml) Pack of 1	£15.68	Intermediate And Long-Acting Insulins
	Humulin M3 Vial 10 ml Vial (100units / ml) Pack of 1	£15.68	Intermediate And Long-Acting Insulins
	Humulin I Cartridge 3 ml Cartridge Pack of 5	£19.08	Intermediate And Long-Acting Insulins
	Humulin I Preloaded Pen 3 ml Disposable Pen (kwikpen) Pack of 5	£21.70	Intermediate And Long-Acting Insulins
	Humulin M3 Preloaded Pen 3 ml Disposable Pen (kwikpen) Pack of 5	£21.70	Intermediate And Long-Acting Insulins
	Insulin Isophane Human (Insulatard Penfill) 100 units/ml suspension for injection 3ml cartridge Pack of 5	£22.90	Intermediate And Long-Acting Insulins
	NovoMix 30 Cartridge (Penfill) 3 ml penfill cartridge Pack of 5	£28.79	Intermediate And Long-Acting Insulins
	Humalog Mix25 Cartridge 3 ml Cartridge Pack of 5	£29.46	Intermediate And Long-Acting Insulins
	NovoMix 30 Prefilled Pen (FlexPen ) 3 ml pre-filled pen Pack of 5	£29.89	Intermediate And Long-Acting Insulins
	Humalog Mix25 Prefilled Pen 3 ml Disposable Pen Pack of 5	£30.98	Intermediate And Long-Acting Insulins
	Insulin glargine (Abasaglar) 100 units/ml solution for injection 3ml cartridges Pack of 5	£35.28	Intermediate And Long-Acting Insulins
	Insulin glargine (Abasaglar KwikPen) 100 units/ml solution for injection 3ml pre-filled pen Pack of 5	£35.28	Intermediate And Long-Acting Insulins
	Insulin Detemir (Levemir Flexpen) 3 ml preloaded pen Pack of 5	£42.00	Intermediate And Long-Acting Insulins
	Insulin Detemir (Levemir Penfill) 3 ml cartridge Pack of 5	£42.00	Intermediate And Long-Acting Insulins
	Insulin Glargine (Lantus) 10 ml vial (100units / ml) Pack of 1	£25.69	Intermediate And Long-Acting Insulins
	Insulin Glargine (Lantus) 3 ml cartridge (for OptiPen / Autopen) Pack of 5	£34.75	Intermediate And Long-Acting Insulins
	Insulin Glargine (Lantus) 3 ml SoloStar pen Pack of 5	£34.75	Intermediate And Long-Acting Insulins
	Insulin Glargine (Lantus) 3 ml OptiSet pen Pack of 5	£41.50	Intermediate And Long-Acting Insulins
	Insulin Degludec (Tresiba) 100 u / ml (3ml cartridge) (Penfill) Pack of 5	£46.60	Intermediate And Long-Acting Insulins
Approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service
	Insulin Degludec (Tresiba Flextouch) 100 u/ml (3ml prefilled pen) Pack of 5	£46.60	Intermediate And Long-Acting Insulins
Insulin degludec (Tresiba) - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service.
	Insulin Degludec (Tresiba Flextouch) 200 u/ml (3ml prefilled pen) Pack of 3	£55.92	Intermediate And Long-Acting Insulins
Insulin degludec (Tresiba) - approved for use in the treatment of type 1 diabetes mellitus in adults, adolescents and children from the age of one year, who are under the care of the paediatric diabetes service.
	Insulin degludec / Liraglutide (Xultophy) 100 units/ml/Liraglutide 3.6mg/ml solution for injection 3ml pre-filled pen Pack of 5	£159.22	Intermediate And Long-Acting Insulins
Xultophy, a combination of liraglutide/insulin degludec, is accepted onto the formulary for patients intolerant of at least two GLP-1 agonists and who may also be on insulin. Prescribing of Xultophy will be undertaken by the Diabetes Team for the first month and guidance on how Xultophy will be titrated up (and any existing insulin titrated down) will be provided by the Diabetes Team. Patients on Xultophy will be supervised by the Team for about 12 months.